4
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: not found
      • Article: not found

      Resultados falsos positivos de galactomanano en pacientes hematológicos adultos tratados con piperacilina-tazobactam

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          <p class="first" id="d11305053e89">In this prospective study including 78 adult patients with haematological malignancy (90 episodes) we performed galactomannan (GM) (Platelia Aspergillus) screening twice weekly for the diagnosis of invasive aspergillosis. There were five proven and four probable invasive aspergillosis cases. The sensitivity, specificity and positive and negative predictive values were 100, 88, 47 and 100%, respectively. There were eight patients with false positive GM (10.2%). In six patients the false GM reactivity was due to the administration of piperacillin-tazobactam (P-T). A significant association was found between false positive GM (= or &gt; 0.5) and the administration of P-T (p &lt; 0.01). Two other patients with no invasive aspergillosis (2.5%) and false GM reactivity had graft versus host disease (GVHD) and one of them had also mucositis grade IV. The kinetic patterns of false positive GM due to P-T is discussed. </p>

          Related collections

          Author and article information

          Journal
          Revista Iberoamericana de Micología
          Revista Iberoamericana de Micología
          Elsevier BV
          11301406
          June 2007
          June 2007
          : 24
          : 2
          : 106-112
          Article
          10.1016/S1130-1406(07)70023-2
          17604427
          536f8910-fee9-4fb5-b221-4658bda1b71a
          © 2007

          https://www.elsevier.com/tdm/userlicense/1.0/

          History

          Comments

          Comment on this article